[go: up one dir, main page]

BRPI0810835A2 - Formulações de hidroquinona ansamicina - Google Patents

Formulações de hidroquinona ansamicina

Info

Publication number
BRPI0810835A2
BRPI0810835A2 BRPI0810835-8A BRPI0810835A BRPI0810835A2 BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2 BR PI0810835 A BRPI0810835 A BR PI0810835A BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2
Authority
BR
Brazil
Prior art keywords
anxamycin
hydroquinone
formulations
hydroquinone formulations
anxamycin hydroquinone
Prior art date
Application number
BRPI0810835-8A
Other languages
English (en)
Inventor
James L Wright
James R Porter
Original Assignee
Infinity Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc
Publication of BRPI0810835A2 publication Critical patent/BRPI0810835A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BRPI0810835-8A 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina BRPI0810835A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91133007P 2007-04-12 2007-04-12
PCT/US2008/060063 WO2008128063A1 (en) 2007-04-12 2008-04-11 Hydroquinone ansamycin formulations

Publications (1)

Publication Number Publication Date
BRPI0810835A2 true BRPI0810835A2 (pt) 2015-06-16

Family

ID=39628966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810835-8A BRPI0810835A2 (pt) 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina

Country Status (10)

Country Link
US (1) US20080255080A1 (pt)
EP (1) EP2134338A1 (pt)
JP (1) JP2010523710A (pt)
CN (1) CN101677991A (pt)
AU (1) AU2008240179A1 (pt)
BR (1) BRPI0810835A2 (pt)
CA (1) CA2684211A1 (pt)
IL (1) IL201283A0 (pt)
MX (1) MX2009010808A (pt)
WO (1) WO2008128063A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4869077B2 (ja) 2003-12-23 2012-02-01 インフィニティー ディスカヴァリー インコーポレイテッド 癌治療に使用するベンゾキノン包含アンサマイシン類のアナログ
US8778921B2 (en) 2008-10-15 2014-07-15 Infinity Pharmaceuticals, Inc. Ansamycin hydroquinone compositions
CN115227692A (zh) * 2022-09-05 2022-10-25 中国医学科学院基础医学研究所 Reblastatin在制备治疗慢性惊厥的药物中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
AU707734B2 (en) * 1995-06-07 1999-07-15 Regents Of The University Of California, The Stabilization of polynucleotide complexes
ZA9811127B (en) * 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
AU749180B2 (en) * 1998-02-18 2002-06-20 Theryte Limited Treating cancer
MXPA03007856A (es) * 2001-03-30 2003-12-04 Us Health Derivado de geldanamicina y metodo de usarlo para tratar cancer.
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
JP2005530689A (ja) * 2002-02-08 2005-10-13 コンフォーマ・セラピューティクス・コーポレイション 改良された薬理学的および生物学的特性を有するアンサマイシン
EP1517698B2 (en) * 2002-06-21 2017-12-06 Novo Nordisk Health Care AG STABILISED SOLID COMPOSITIONS OF FACTOR VIIa POLYPEPTIDES
JP4869077B2 (ja) * 2003-12-23 2012-02-01 インフィニティー ディスカヴァリー インコーポレイテッド 癌治療に使用するベンゾキノン包含アンサマイシン類のアナログ
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20070048323A1 (en) * 2004-02-20 2007-03-01 Rubin J P Antibody treatment of lipomatous tumors
WO2006098761A2 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Hsp90 inhibitors, methods of making and uses therefor
US20100279994A1 (en) * 2005-06-21 2010-11-04 Inifinity Discovery, Inc. Ansamycin Formulations and Methods of Use Thereof
JP2009518302A (ja) * 2005-12-01 2009-05-07 コンフォーマ・セラピューティクス・コーポレイション アンサマイシン含有組成物
EA018573B1 (ru) * 2006-09-22 2013-09-30 Фармасайкликс, Инк. Ингибиторы тирозинкиназы брутона

Also Published As

Publication number Publication date
JP2010523710A (ja) 2010-07-15
US20080255080A1 (en) 2008-10-16
EP2134338A1 (en) 2009-12-23
IL201283A0 (en) 2010-05-31
AU2008240179A1 (en) 2008-10-23
CN101677991A (zh) 2010-03-24
CA2684211A1 (en) 2008-10-23
MX2009010808A (es) 2009-10-29
WO2008128063A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
BRPI0814188A2 (pt) Formulações
BRPI0814252A2 (pt) Formulações de anticorpo
BRPI0814003A2 (pt) Formulações de anticorpo
DK2068886T3 (da) Lipidholdige præparater
ES2527409T4 (es) Formulaciones de inhibidores de DPP IV
DK2203462T4 (da) Nukleosid-phosphoramidat-prodrugs
DE602008006301D1 (de) Koaxialnadelanordnung
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2514750T3 (da) Bromphenylsubstituerede thiazolyldihydropyrimidiner
DE112008003636A5 (de) Mehrzuggruppierer
EP2152479A4 (en) TREE SHEAR
EP2160187A4 (en) SPIROINDALONE
DE602007007755D1 (de) Fußplatte
DK2125048T3 (da) Præparat
EP2211752A4 (en) biopulp
EP2149500A4 (en) Electron beam sterilizer
FI20075277A0 (fi) Radiaalisiipipyörä
BRPI0812994A2 (pt) Microbiocidas
EP2237903A4 (en) METAL BENDING APPARATUS
DE602008000912D1 (de) Schaltanlage
FI20075524A0 (fi) Suotokuristinjärjestely
BRPI0809653A2 (pt) Formulações líquidas de manoproteína
DE502008001694D1 (de) Mitfahrhubwagen
FI20070655A0 (fi) Imuhihnakuljetin
DE602008000292D1 (de) Werkzeughaltepositioniervorrichtung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.